Back to Top
Narnatumab Biosimilar - Research Grade
$710.00 - $6,900.00
Narnatumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
MST1Rï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
Q04912
Shipping Conditions
Blue ice
Background
The RON receptor tyrosine kinase (MST1R) signals through macrophage-stimulating protein to influence cell motility, survival, and tumor invasion, drawing interest across oncology research. Offered as an unconjugated, non-therapeutic analog of narnatumab, this recombinant human IgG1 kappa antibody recognizes MST1R and is designated for research use only (RUO). It is purified to low endotoxin for reliable in vivo performance and manufactured in scalable milligram-to-gram lots to support high-throughput and bulk laboratories. Researchers use it as a receptor-blockade control and reagent in functional assays, in vitro screening, preclinical tumor models, and antibody-drug-conjugate or biologics development.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review










